Mechanisms and prevention of restenosis after coronary angioplasty;Mechanismen und pravention der restenose nach koronarangioplastie

Schweizerische Medizinische Wochenschrift

Volumn 128, Issue 13, 1998, Pages 497-507

  Drechsel, S ^a,c   Bertel, O ^a   Lafont, A ^b  

^a Medizinische Klinik Zurich   (Switzerland)

^b Hopital Boucicaut   (France)

^c TRIEMLI HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ANTICOAGULANT AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; STEROID;

ARTERY INTIMA PROLIFERATION; CORONARY ARTERY OBSTRUCTION; GENE THERAPY; GROWTH INHIBITION; HUMAN; OXIDATION REDUCTION REACTION; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE; WOUND HEALING; ANIMAL; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; EXTRACELLULAR MATRIX; METHODOLOGY; PATHOLOGY; PREMEDICATION; RECURRENT DISEASE; STENT; VASCULAR ENDOTHELIUM;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTICOAGULANTS; CORONARY DISEASE; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; ESTROGENS; EXTRACELLULAR MATRIX; HUMANS; PREMEDICATION; RECURRENCE; STENTS; STEROIDS;

EID: 0032574353     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988;12:616-23.
2. Franklin SM, Faxon DP. Pharmacologic prevention of restenosis after coronary angioplasty: review of randomized clinical trials. Coronary Artery Dis 1993;4:232-42.
3. Goerre S. Herzeingriffe in der Schweiz 1995. Schweiz Rundschau Med Prax 1997;86:425-31.
4. Califf RM, Fortin DF, Frid DJ, Harlan WR III, Ohman EM, Bengtson JR, et al. Restenosis after coronary angioplasty: An overview. J Am Coll Cardiol 1991;17:2B-13B.
5. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME, et al. A definition of initial fatty streak and intermediate lesions of atherosclerosis. Circulation 1994;89: 2462-78.
6. Waller BF. Pathology of transluminal balloon angioplasty used in the treatment of coronary heart disease. Hum Pathol 1987;18:476-84.
7. Chen YH, Chen YL, Lin SH, Chou CY, Mar GY, Chang MS, Wang SP. Electron microscopic studies of phenotypic modulation of smooth muscle cells in coronary arteries of patients with unstable angina pectoris and postangioplasty restenosis. Circulation 1997;95:1169-75.
8. Scott NA, Cipolla GD, Ross CE, Dunn B, Martin FHJ, Simonet L, Wilcox JN. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996; 93:2178-87.
9. Shi Y, Pieniek M, Fard A, O'Brien J, Mannion JD, Zalewski A. Adventitial remodeling after coronary arterial injury. Circulation 1996;93:340-8.
10. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8.
11. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 1995;91: 2703-11.
12. White E. p53, guardian of Rb. Nature 1994;371:21-2.
13. Currier JW, Faxon DP. Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target? J Am Coll Cardiol 1995;25:516-20.
14. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316: 1371-407.
15. Kakuta T, Currier JW, Haudenschild CC, Ryan TJ, Faxon DP. Differences in compensatory vessel enlargement, not intimai formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation 1994; 89:2809-15.
16. Losordo DW, Rosenfield K, Kaufman J, Pieczek A, Isner JM. Focal compensatory enlargement of human arteries in response to progressive atherosclerosis: in vivo documentation using intravascular ultrasound. Circulation 1994;89: 2570-7.
17. Post MJ, Borst C, Kuntz RE. The relative importance of arterial remodeling compared with intimai hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan Micropig. Circulation 1994;89:2816-21.
18. Langille, BL O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 1986;231:405-7.
19. Langille BL, Bendeck MP, Keeley FW. Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow. Am J Physiol 1989;256:H931-9.
20. Friedman MH, Bargeron CB, Duncan DD, Hutchins GM, Mark FF. Effects of arterial compliance and non-newtonian rheology on correlations between intimai thickness and wall shear. J Biomech Eng 1992;114:317-20.
21. Di Mario C, Piek JJ, Vrints C, Heyndrickx G, Gurne O, Geschwind H, et al., for the DEBATE study group. Are flow velocity measurements after PTCA predictive of angina or of a positive exercise stress test early after balloon angioplasty. Circ 1995;92:I-264.
22. Kuntz RE, Hinohara T, Safian RD, Selmon MR, Simpson JB, Baim DS. Restenosis after directional atherectomy, effects of luminal diameter and deep wall excision. Circulation 1992; 86:1394-9.
23. Topol EJ, Leya F, Pinkerton CA, Whitlow PL, Hofling B, Simonton CA, et al. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. N Engl J Med 1993;329: 221-7.
24. de Vrey E, Mintz GS, Kimura T, Nobuyoshi M, Popma JJ, Mehlman MD, et al. Arterial remodeling after directional coronary atherectomy: a volumetric analysis from the serial ultrasound restenosis (SURE) trial [abstract]. J Am Coll Cardiol 1997;29(Suppl A):280A.
25. Hosokawa H, Kato O, Tamai H, Yamaguchi T, Aizawa T, Suzuki T. Role of adjunctive balloon angioplasty following coronary atherectomy: A serial intravascular ultrasound analysis from the ABACAS Trial [abstract]. J Am Coll Cardiol 1997;29(Suppl A):281A.
26. Bairn DS, Cutlip D, Ho KK, Popma JJ, Senerchia C, Kuntz RE. Acute results of directional coronary atherectomy in the Balloon Versus Optimal Atherectomy Trial (BOAT) pilot phase. Coronary Artery Disease 1996;7:290-3.
27. Bowers TR, Stewart RE, O'Neill, Reddy VM, Safian RD. Effect of rotablator atherectomy and adjunctive balloon angioplasty on coronary blood flow. Circulation 1997;95: 1157-64.
28. Ellis SG, Popma JJ, Buchbinder M, Franco I, Leon MB, Kent KM, et al. Relation of clinical presentation, stenosis, morphology, and operator technique to the procedural results of rotational atherectomy and rotational atherectomy-facilitated angioplasty. Circulation 1994;89:882-92.
29. Vandormael M, Reifart N, Preusler W, Schwarz F, Störger H, Hofmann M, et al. Six-months follow-up results following excimer laser angioplasty, rotational atherectomy and balloon angioplasty for complex lesions: ERBAC study [abstract]. Circulation 1994;90:I-213 .
30. Macaya C, Serruys PW, Ruygrok P, Suryapranata H, Mast G, Klugmann S, et al. Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. J Am Coll Cardiol 1996; 27:255-61.
31. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
32. Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 1996;334: 561-6.
33. Sirnes PA, Golf S, Myreng Y, Molstad P, Emanuelsson H, Albertsson P, et al. Stenting in chronic coronary occlusion (SICCO): A randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996;28:1444-51.
34. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffè PA. A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descendingcoronary artery. N Engl J Med 1997;336:817-22.
35. Karillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30-day clinical outcome of the French Multicenter Registry. Circulation 1996; 94:1519-27.
36. Leon MD, Baim DS, Gordon P, Giambartolomei A, Williams DO, Diver DJ, et al. Clinical and angiographic results from the Stent Anticoagulation Regimen Study (STARS) [abstract]. Circulation 1996;94(Suppl I):I-685.
37. Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, et al. Small stent size and intimai hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995;26:720-4.
38. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Chuang C, et al. Intravascular ultrasound predictors of restenosis after percutaneous transcatheter coronary revascularization. J Am Coll Cardiol 1996;27:1678-87.
39. Aggarwal RK, Ireland DC, Azurin MA, Ezekowitz MD, de Bono DP, Gershlick AH. Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody. Circulation 1996;94:3311-7.
40. Serruys PW, et al., on the behalf of Benestent-II Study Group. Heparin-coated Palmaz-Schatz stents in human coronary arteries. Circulation 1996;93:412-22.
41. Serruys PW, Klein W, Tijssen JP, Rutsch W, Heyndrickx GR, Emanuelsson H, et al. Evaluation of ketanserin in the prevention of restenosis after PTCA. Circulation 1993;88: 1588-601.
42. Knudtson ML, Flintoft VF, Roth DL, Hansen JL, Duff HJ. Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1990;15:691-7.
43. Serruys PW, Herrman JP, Simon R, Rutsch W, Bode C, et al. A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 1995; 333:757-63.
44. Bittl JA, Strony J, Brinker JA, Ahmed WH, Meckel CR, et al. Treatment with bivalirudin (hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 1995;333:764-9.
45. Faxon DP, Spiro TE, Minor S, Coté G, Douglas J, Gottlieb R, et al., for the ERA Investigators: Low molecular weight heparin in prevention of restenosis after angioplasty: Results of enoxaparin restenosis (ERA) trial. Circulation 1994;90: 908-14.
46. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330: 956-61.
47. The EPILOG-Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during PTCA. N Engl J Med 1997;336:1689-96.
48. The CAPTURE investigators. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997;349:1429-35.
49. Whitworth HB, Roubin GS, Hollman J, Meier B, Leimgruber PP, Douglas JS Jr, et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1986;8:1271-6.
50. Corcos T, David PR, Val PG, Renkin J, Dangiosse V, Rapold HG, Bourassa MG. Failure of diltiazem to prevent restenosis after percutaneous transluminal coronary angioplasty. Am Heart J 1985;109:926-31.
51. The ACCORD Study. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. Circulation 1997;95: 83-9.
52. Cairns JA, Gill J, Morton B, Roberts R, Gent M, Hirsh J, et al., for the EMPAR Collaborators. Fish oils and low-molecular-weight heparin for the reduction of restenosis after PTCA. Circulation 1996;94:1553-60.
53. Nakamura Y, Yamaoka O, Uchida K, Morgami N, Sugimot Y, Fujita T, et al., and the SHIga Pravastatin Study (SHIPS) Group. Pravastatin reduces restenosis after coronary angioplasty of high grade stenotic lesions: results of SHIPS (SHIga Pravastatin Study). Cardiovasc Drugs Ther 1996;10:4:475-83.
54. Weintraub WS, Boccuzzi SJ, Klein JL, Kosinsky AS, King S III, Ivanhoe R, et al., and the Lovastatin Restenosis Trial Study Group: Lack of effect of lovastatin on restenosis after coronary angioplasty. N Engl J Med 1994;331:1331-7.
55. Daemen MJAP, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991;68: 450-6.
56. MERCATOR Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992;86:100-10.
57. Faxon DP on behalf of the MARCATOR investigators. Effect of high-dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol 1995;25:362-9.
58. Pepine CJ, Hirshfeld JW, MacDonald RG, Henderson MA, Bass TA, Goldberg S, et al., for the M-HEART GROUP: A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty. Circulation 1990;81:1753-61.
59. O'Keefe JH, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzler GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol 1992;19:1597-600.
60. Lincoff MA, Furst JG, Ellis SG, Tuch RJ, Topol EJ. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997;29:808-16.
61. O'Brien JE, Peterson ED, Keeler GP, Berdan LG, Ohman EM, Faxon DP, et al. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. J Am Coll Cardiol 1996;28:1111-8.
62. Tardif JC, Côté G, Lespérance J, Bourassa M, Lambert J, Doucet S, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997;337:365-72.
63. Emanuelsson H, Beatt KJ, Bagger JP, Balcon R, Heikkilä J, Piessens J, et al., for the European Angiopeptin Study Group. Circulation 1995;91:1689-96.
64. Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fabbri M, et al., for the STARC Investigators. Trapidil (Triazolopyrimidine), a PDGF-antagonist, reduces restenosis after PTCA. Circulation 1994;90:2710-5.
65. Lincoff AM, Topol EJ, Ellis SG. Local drug delivery for the prevention of restenosis. Circulation 1994;90:2070-84.
66. Condado JA. Long-term angiographic and clinical outcome after PTCA and intracoronary radiation therapy in humans. Circulation 1997;96:727-32.
67. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997;336:1697-703.
68. Verin V, Urban P, Popowsld Y, Schwager M, Nouet P, Dorsaz PA, et al. Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty. Circulation 1997;95:1138-44.
69. Nabel EG, Pompili VJ, Plautz GE, Nabel GJ. Gene transfer and vascular disease. Cardiovasc Res 1994;28:445-55.
70. Roquè F, Mon G, Belardi J, Rodriguez A, Grinfeld L, Fischman D, Shi Y, Zalewski A. Safety of intracoronary administration of c-myc antisense after PTCA [abstract]. J Am Coll Cardiol 1997;29(Suppl):317A.